Search bioRxiv⌕ Search

Biology subjects

Sundaramurthi, J. C.

Publications and source records attributed to Sundaramurthi, J. C..

2 recordsLinked to original sources

An algorithmic framework for isoform-specific functional analysis

Gene Ontology (GO) overrepresentation analysis characterizes the biological mechanisms common to sets of differentially expressed genes identified by high-throughput experiments. To date, GO overrepresentation analysis has mainly been used to evaluate differentially expressed genes, but short- and long-read RNA-seq technologies now allow increasingly accurate identification of differential alternative splicing. The function of most splice isoforms remain unknown, but if acccurate predictions could be made, overrepresentation analysis could be applied to differentially spliced isoforms to assess the functional implications of alternative splicing in RNA-seq experiments. We present isopret (Isoform Interpretation), a new paradigm for isoform function prediction based on the expectation-maximization framework. isopret leverages the relationships between sequence and functional isoform similarity to infer isoform specific functions in a highly accurate fashion. This enabled us to adapt GO overrepresentation analysis, which to date has been limited to differential gene expression, to be extended to assess overrepresentation of GO annotations in differentially spliced isoforms. An analysis of 100 RNA-seq studies including investigations of development, cancer, and common disease demonstrated that expression and splicing regulate different sets of biological functions. We make isopret predictions freely available in a desktop application that can be used to analyze differential expression and splicing in any bulk RNA-seq dataset.

bioinformatics↗

In silico and in vitro screening of FDA-approved drugs for potential repurposing against tuberculosis

MotivationRepurposing of known drugs to newer clinical conditions is a promising avenue for finding novel therapeutic applications for tuberculosis.\n\nMethodsWe performed docking-based virtual screening for 1554 known drugs against two of the potential drug targets, namely trpD and coaA of M. tuberculosis. In the first round of in silico screening we used rigid docking using Glide and AutoDock Vina. We subjected the consistently ranked drugs for induced-fit docking by these tools against the same target proteins. We performed luciferase reporter phage (LRP) assay to determine the biological activity of five selected drugs against M. tuberculosis.\n\nResultsWe observed lymecycline and cefpodoxime to be active against drug susceptible and drug resistant strains of M. tuberculosis. In addition, lymecycline and cefpodoxime showed synergistic activity with rifampin and isoniazid against M. tuberculosis.\n\nConclusionOur results suggest that lymecycline and cefpodoxime have potential to be repurposed for the treatment of tuberculosis.

bioinformatics↗